Targeted treatments in advanced renal cell carcinoma: focus on axitinib

Antiangiogenesis options have evolved rapidly in the last few years, with an increasing number of agents currently approved by the US Food and Drug Administration and European Medicines Agency. Angiogenesis inhibitors have been shown to be very effective for the treatment of metastatic renal cancer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Verzoni, Elena, Grassi, Paolo, Testa, Isabella, Iacovelli, Roberto, Biondani, Pamela, Garanzini, Enrico, De Braud, Filippo, Procopio, Giuseppe
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2014
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3977458/
https://ncbi.nlm.nih.gov/pubmed/24715765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S37098
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki